Quince Therapeutics (QNCX) Stock: Buy, Sell, or Hold?
QNCX - Quince Therapeutics, Inc. Common Stock
$31.73
2.37 (8.07%)
▲
5d:
+8.66%
30d:
+9.56%
90d:
+83.94%
HOLD
MODERATE Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When QNCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: QNCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: QNCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: QNCX is currently trading at $31.73, which is considered extended relative to its 30-day fair value range of $27.85 to $31.07.
Technical Outlook: Technically, QNCX is in a strong uptrend. Immediate support is located at $26.45, while resistance sits at $37.00. The stock is showing strong short-term momentum, up 8.1% recently.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $75.43 (+137.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, QNCX is in a strong uptrend. Immediate support is located at $26.45, while resistance sits at $37.00. The stock is showing strong short-term momentum, up 8.1% recently.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $75.43 (+137.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$27.85 -
$31.07
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (56/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.1%)
- BULLISH: Trading 137.7% below Wall St target ($75.43)
- NEUTRAL: Bottoming setup forming (56/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$27.85 -
$31.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$26.45
Resistance Level
$37.00
Current Trend
Strong Uptrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.78
Wall Street Target
$75.43
(+137.7%)
Share & Embed Analysis
Last updated: October 24, 2026 3:53 AM ET
Data refreshes hourly during market hours. Next update: 4:53 AM
Data refreshes hourly during market hours. Next update: 4:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 73 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 72 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 56 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 47 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 59 HOLD |
